American International Group’s Cullinan Oncology CGEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,742
Closed -$217K 515
2024
Q1
$217K Sell
12,742
-1,223,822
-99% -$18.9M ﹤0.01% 2099
2023
Q4
$12.6M Buy
1,236,564
+972
+0.1% +$8.61K 0.05% 272
2023
Q3
$11.2M Buy
1,235,592
+423
+0% +$4.41K 0.07% 296
2023
Q2
$13.3M Sell
1,235,169
-1,180
-0.1% -$12.5K 0.08% 239
2023
Q1
$12.6M Sell
1,236,349
-1,729
-0.1% -$19.1K 0.08% 250
2022
Q4
$13.1M Sell
1,238,078
-53
-0% -$644 0.09% 224
2022
Q3
$15.9M Buy
1,238,131
+463
+0% +$6.24K 0.12% 150
2022
Q2
$15.9M Buy
1,237,668
+1,108
+0.1% +$12.6K 0.11% 163
2022
Q1
$12.9M Sell
1,236,560
-904
-0.1% -$12.2K 0.07% 313
2021
Q4
$19.1M Sell
1,237,464
-413
-0% -$8.24K 0.1% 188
2021
Q3
$27.9M Buy
1,237,877
+6,756
+0.5% +$181K 0.15% 108
2021
Q2
$31.7K Buy
1,231,121
+1,223,471
+15,993% +$37.6M 0.11% 143
2021
Q1
$319 Buy
+7,650
New +$311K ﹤0.01% 2097

Other funds holding CGEM